Kisspeptin for GLP-1 Menstrual Disruptions: FDA Vote Impact
The FDA panel vote on GLP-1 agonists highlights overlooked menstrual disruptions. Kisspeptin, a hypothalamic peptide, may restore reproductive
Read more →Ontario Peptides
News
Kisspeptin for GLP-1 Menstrual Irregularities: FDA Panel Vote Impact
Kisspeptin's role in GLP-1-induced menstrual irregularities gains new context from the FDA peptide panel vote. This article examines the science
Read more →GHK-Cu for Postpartum Skin and Hair After Tirzepatide
GHK-Cu, a copper peptide studied at the St. Petersburg Institute, may support postpartum skin and hair recovery after tirzepatide use. Research on
Read more →Kisspeptin Counters GLP-1 Menstrual Disruption
Kisspeptin may counter GLP-1 agonist-induced menstrual disruptions by restoring GnRH pulsatility. This article examines the bioregulator rationale, St
Read more →Kisspeptin for GLP-1-Induced Menstrual Disruptions
Menstrual disruptions from GLP-1 agonists like Tirzepatide and Semaglutide may stem from suppressed Kisspeptin. This article explores how Kisspeptin
Read more →